Investor News Biovara to merge with Nuformix Plc 11 November, 2026 | Investor News Read More → Biovara closes a £ 1 million equity capital raise at an £ 8m pre-money valuation. 4 November, 2026 | Investor News Read More → Professor Jaclyn Smith – regarded as world leading expert on chronic cough, including Lung Cancer Cough, endorses Biovara’s clinical approach 5 November, 2025 | Investor News Read More → Biovara approves share capital split prior to fund raising 12 June, 2025 | Investor News Read More → ACF Research publication of independent thematic research note on Lung Cancer Cough market 25 April, 2025 | Investor News Read More → Biovara adopts ESG policy 14 April, 2025 | Investor News Read More → Biovara Limited incorporated as a wholly owned subsidiary of Oxilio Limited 7 April, 2025 | Investor News Read More →
